Literature DB >> 20548092

Genomic instability after allogeneic hematopoietic cell transplantation is frequent in oral mucosa, particularly in patients with a history of chronic graft-versus-host disease, and rare in nasal mucosa.

Faisal M Khan1, Sarah Sy, Polly Louie, Alejandra Ugarte-Torres, Noureddine Berka, Gary D Sinclair, Douglas A Stewart, James A Russell, Jan Storek.   

Abstract

Genomic instability (GI) of cells may lead to their malignant transformation. Carcinoma after hematopoietic cell transplantation (HCT) frequently involves some (eg, oral) but not other (eg, nasal) epithelia. We examined GI in oral and nasal mucosal specimens from 105 subjects, including short-term (7-98 days, n = 32) and long-term (4-22 yrs, n = 25) allogeneic HCT survivors. Controls included autologous HCT survivors (n = 11), patients treated with chemotherapy without HCT (n = 9) and healthy controls (n = 27). GI was detected in 60% oral versus only 4% nasal specimens in long-term allogeneic HCT survivors (P < .001). None of the controls showed GI. In oral specimens, GI was significantly associated with history of oral chronic graft-versus-host disease (cGVHD). We conclude that GI after HCT is frequent in some (oral) but rare in other (nasal) epithelia. This may explain why some epithelia (especially those involved with cGVHD) are prone to develop cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20548092     DOI: 10.1182/blood-2009-10-249201

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  Oral Complications of Chronic Graft-Versus-Host Disease.

Authors:  Jane M Fall-Dickson; Steven Z Pavletic; Jacqueline W Mays; Mark M Schubert
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

2.  DNA chimerism and its consequences after allogeneic hematopoietic cell transplantation.

Authors:  Maria Themeli; Miguel Waterhouse; Juergen Finke; Alexandros Spyridonidis
Journal:  Chimerism       Date:  2011-01

3.  Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?

Authors:  Parinda A Mehta; Chie Emoto; Tsuyoshi Fukuda; Brian Seyboth; Ashley Teusink-Cross; Stella M Davies; Jamie Wilhelm; Kirsten Fuller; Alexander A Vinks; Farid Boulad
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-18       Impact factor: 5.742

4.  Long-term safety of photobiomodulation therapy for oral mucositis in hematopoietic cell transplantation patients: a 15-year retrospective study.

Authors:  Letícia Mello Bezinelli; Luciana Corrêa; Cristina Vogel; Jose Mauro Kutner; Andreza Feitosa Ribeiro; Nelson Hamerschlak; Carlos de Paula Eduardo; Cesar Augusto Migliorati; Fernanda de Paula Eduardo
Journal:  Support Care Cancer       Date:  2021-05-22       Impact factor: 3.603

5.  p53 phosphorylation and TP53 copy-number alterations in chronic graft-versus-host oral lichen preceding squamous cell carcinoma.

Authors:  Maxime Battistella; Wendy Cuccuini; Morad Elbouchtaoui; Christophe Leboeuf; Louis-François Plassa; Fatiha Bouhidel; Arnaud Rigolet; Véronique Meignin; Gérard Socié; Philippe Ratajczak; Anne Janin
Journal:  J Invest Dermatol       Date:  2013-09-04       Impact factor: 8.551

Review 6.  Oral health in geroscience: animal models and the aging oral cavity.

Authors:  Jonathan Y An; Richard Darveau; Matt Kaeberlein
Journal:  Geroscience       Date:  2017-12-27       Impact factor: 7.713

7.  Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.

Authors:  Parinda A Mehta; Stella M Davies; Thomas Leemhuis; Kasiani Myers; Nancy A Kernan; Susan E Prockop; Andromachi Scaradavou; Richard J O'Reilly; David A Williams; Leslie Lehmann; Eva Guinan; David Margolis; K Scott Baker; Adam Lane; Farid Boulad
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 8.  Oral verruciform xanthoma associated with chronic graft-versus-host disease: a report of five cases and a review of the literature.

Authors:  Shokoufeh Shahrabi Farahani; Nathaniel S Treister; Zainab Khan; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2011-02-09

9.  Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.

Authors:  H Mawardi; S Elad; M E Correa; K Stevenson; S-B Woo; S Almazrooa; R Haddad; J H Antin; R Soiffer; N Treister
Journal:  Bone Marrow Transplant       Date:  2011-04-04       Impact factor: 5.483

Review 10.  DNA damage and repair in epithelium after allogeneic hematopoietic stem cell transplantation.

Authors:  Maria Themeli; Alexandros Spyridonidis
Journal:  Int J Mol Sci       Date:  2012-11-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.